Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026
Share Facebook Twitter LinkedIn Pinterest Email Investors in the airline sector may benefit from the Spirit bankruptcy
Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026